{"entity":{"type":"insider","cik":"0001680307","url":"/insider/0001680307","json_url":"/insider/0001680307.json","name":"Deerfield Private Design Fund IV, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":65,"n_filings":25,"first":"2018-02-23","last":"2026-03-02","span_basis":"filed_date"},"name_variants":[{"name":"Deerfield Private Design Fund IV, L.P.","source":"filing","n_filings":25,"first_seen":"2018-02-23","last_seen":"2026-03-02"}],"transactions":[{"id":6136162,"accession":"0001193805-26-000205","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-26-000205","line_url":"/filing/0001193805-26-000205#line-4","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Flynn James E","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000000.0,"shares_display":"2,000,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","shares_owned_after":6207982.0,"shares_owned_after_display":"6,207,982","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-02","scope":"insider"},{"id":6136158,"accession":"0001193805-26-000205","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-26-000205","line_url":"/filing/0001193805-26-000205#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Flynn James E","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1084012.0,"shares_display":"1,084,012","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":5420060.0,"total_display":"5,420,060.00","shares_owned_after":10622957.0,"shares_owned_after_display":"10,622,957","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-02","scope":"insider"},{"id":6136154,"accession":"0001193805-26-000205","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-26-000205","line_url":"/filing/0001193805-26-000205#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Flynn James E","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1084010.0,"shares_display":"1,084,010","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":5420050.0,"total_display":"5,420,050.00","shares_owned_after":10622928.0,"shares_owned_after_display":"10,622,928","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-02","scope":"insider"},{"id":6136150,"accession":"0001193805-26-000205","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-26-000205","line_url":"/filing/0001193805-26-000205#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Flynn James E","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":831978.0,"shares_display":"831,978","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":4159890.0,"total_display":"4,159,890.00","shares_owned_after":8153107.0,"shares_owned_after_display":"8,153,107","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-02","scope":"insider"},{"id":4579373,"accession":"0001193805-25-001648","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-25-001648","line_url":"/filing/0001193805-25-001648#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Nuvalent, Inc.","issuer_ticker":"NUVL","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD PARTNERS, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; Deerfield Mgmt L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":371287.0,"shares_display":"371,287","price_per_share":95.445,"price_display":"95.44","price_state":"stated","total_value":35437487.715,"total_display":"35,437,487.72","shares_owned_after":8299225.0,"shares_owned_after_display":"8,299,225","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-24","scope":"insider"},{"id":4579367,"accession":"0001193805-25-001648","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-25-001648","line_url":"/filing/0001193805-25-001648#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Nuvalent, Inc.","issuer_ticker":"NUVL","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD PARTNERS, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; Deerfield Mgmt L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":371287.0,"shares_display":"371,287","price_per_share":95.445,"price_display":"95.44","price_state":"stated","total_value":35437487.715,"total_display":"35,437,487.72","shares_owned_after":8299225.0,"shares_owned_after_display":"8,299,225","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-24","scope":"insider"},{"id":5143787,"accession":"0001193805-25-001155","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-25-001155","line_url":"/filing/0001193805-25-001155#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt L.P.; Deerfield Mgmt IV, L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3387539.0,"shares_display":"3,387,539","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":10840124.8,"total_display":"10,840,124.80","shares_owned_after":9538945.0,"shares_owned_after_display":"9,538,945","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-31","filed_date":"2025-08-04","scope":"insider"},{"id":5143783,"accession":"0001193805-25-001155","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-25-001155","line_url":"/filing/0001193805-25-001155#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt L.P.; Deerfield Mgmt IV, L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3387529.0,"shares_display":"3,387,529","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":10840092.8,"total_display":"10,840,092.80","shares_owned_after":9538918.0,"shares_owned_after_display":"9,538,918","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-31","filed_date":"2025-08-04","scope":"insider"},{"id":5143779,"accession":"0001193805-25-001155","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-25-001155","line_url":"/filing/0001193805-25-001155#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt L.P.; Deerfield Mgmt IV, L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2599932.0,"shares_display":"2,599,932","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":8319782.4,"total_display":"8,319,782.40","shares_owned_after":7321129.0,"shares_owned_after_display":"7,321,129","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-31","filed_date":"2025-08-04","scope":"insider"},{"id":4426836,"accession":"0001193805-25-000959","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-25-000959","line_url":"/filing/0001193805-25-000959#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":370075.0,"shares_display":"370,075","price_per_share":18.46,"price_display":"18.46","price_state":"stated","total_value":6831584.5,"total_display":"6,831,584.50","shares_owned_after":4887254.0,"shares_owned_after_display":"4,887,254","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-27","filed_date":"2025-07-01","scope":"insider"},{"id":4426833,"accession":"0001193805-25-000959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-25-000959","line_url":"/filing/0001193805-25-000959#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":370074.0,"shares_display":"370,074","price_per_share":18.46,"price_display":"18.46","price_state":"stated","total_value":6831566.04,"total_display":"6,831,566.04","shares_owned_after":4887254.0,"shares_owned_after_display":"4,887,254","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-27","filed_date":"2025-07-01","scope":"insider"},{"id":3218003,"accession":"0001193805-24-001348","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-8","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9554.0,"shares_display":"9,554","price_per_share":17.77,"price_display":"17.77","price_state":"stated","total_value":169774.58,"total_display":"169,774.58","shares_owned_after":5257329.0,"shares_owned_after_display":"5,257,329","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-13","scope":"insider"},{"id":3217998,"accession":"0001193805-24-001348","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-7","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9553.0,"shares_display":"9,553","price_per_share":17.77,"price_display":"17.77","price_state":"stated","total_value":169756.81,"total_display":"169,756.81","shares_owned_after":5257328.0,"shares_owned_after_display":"5,257,328","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-13","scope":"insider"},{"id":3217993,"accession":"0001193805-24-001348","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-6","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7854.0,"shares_display":"7,854","price_per_share":17.16,"price_display":"17.16","price_state":"stated","total_value":134774.64,"total_display":"134,774.64","shares_owned_after":5266881.0,"shares_owned_after_display":"5,266,881","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-13","scope":"insider"},{"id":3217985,"accession":"0001193805-24-001348","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-5","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7853.0,"shares_display":"7,853","price_per_share":17.16,"price_display":"17.16","price_state":"stated","total_value":134757.48,"total_display":"134,757.48","shares_owned_after":5266883.0,"shares_owned_after_display":"5,266,883","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-13","scope":"insider"},{"id":3217981,"accession":"0001193805-24-001348","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-4","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":223632.0,"shares_display":"223,632","price_per_share":18.15,"price_display":"18.15","price_state":"stated","total_value":4058920.8,"total_display":"4,058,920.80","shares_owned_after":5274736.0,"shares_owned_after_display":"5,274,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider"},{"id":3217975,"accession":"0001193805-24-001348","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":223632.0,"shares_display":"223,632","price_per_share":18.15,"price_display":"18.15","price_state":"stated","total_value":4058920.8,"total_display":"4,058,920.80","shares_owned_after":5274735.0,"shares_owned_after_display":"5,274,735","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider"},{"id":3217963,"accession":"0001193805-24-001348","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40596.0,"shares_display":"40,596","price_per_share":17.45,"price_display":"17.45","price_state":"stated","total_value":708400.2,"total_display":"708,400.20","shares_owned_after":5498368.0,"shares_owned_after_display":"5,498,368","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider"},{"id":3217957,"accession":"0001193805-24-001348","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40596.0,"shares_display":"40,596","price_per_share":17.45,"price_display":"17.45","price_state":"stated","total_value":708400.2,"total_display":"708,400.20","shares_owned_after":5498367.0,"shares_owned_after_display":"5,498,367","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider"},{"id":3243032,"accession":"0001193805-24-001275","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-24-001275","line_url":"/filing/0001193805-24-001275#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Nuvalent, Inc.","issuer_ticker":"NUVL","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Flynn James E; Deerfield Mgmt IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund IV, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":97.75,"price_display":"97.75","price_state":"stated","total_value":97750000.0,"total_display":"97,750,000.00","shares_owned_after":8670512.0,"shares_owned_after_display":"8,670,512","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-22","filed_date":"2024-10-24","scope":"insider"},{"id":3243030,"accession":"0001193805-24-001275","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-24-001275","line_url":"/filing/0001193805-24-001275#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Nuvalent, Inc.","issuer_ticker":"NUVL","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Flynn James E; Deerfield Mgmt IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund IV, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":97.75,"price_display":"97.75","price_state":"stated","total_value":97750000.0,"total_display":"97,750,000.00","shares_owned_after":8670512.0,"shares_owned_after_display":"8,670,512","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-22","filed_date":"2024-10-24","scope":"insider"},{"id":2793026,"accession":"0001193805-24-000360","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193805-24-000360","line_url":"/filing/0001193805-24-000360#line-5","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Mgmt L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); DEERFIELD PARTNERS, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":114906.0,"shares_display":"114,906","price_per_share":10.7,"price_display":"10.70","price_state":"stated","total_value":1229494.2,"total_display":"1,229,494.20","shares_owned_after":11528863.0,"shares_owned_after_display":"11,528,863","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-12","filed_date":"2024-03-12","scope":"insider"},{"id":2793022,"accession":"0001193805-24-000360","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-24-000360","line_url":"/filing/0001193805-24-000360#line-4","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Mgmt L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); DEERFIELD PARTNERS, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94567.0,"shares_display":"94,567","price_per_share":10.92,"price_display":"10.92","price_state":"stated","total_value":1032671.64,"total_display":"1,032,671.64","shares_owned_after":11731809.0,"shares_owned_after_display":"11,731,809","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-12","scope":"insider"},{"id":2793016,"accession":"0001193805-24-000360","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-24-000360","line_url":"/filing/0001193805-24-000360#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Mgmt L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); DEERFIELD PARTNERS, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88040.0,"shares_display":"88,040","price_per_share":11.13,"price_display":"11.13","price_state":"stated","total_value":979885.2,"total_display":"979,885.20","shares_owned_after":11643769.0,"shares_owned_after_display":"11,643,769","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-12","scope":"insider"},{"id":2793010,"accession":"0001193805-24-000360","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-24-000360","line_url":"/filing/0001193805-24-000360#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Mgmt L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); DEERFIELD PARTNERS, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47992.0,"shares_display":"47,992","price_per_share":10.92,"price_display":"10.92","price_state":"stated","total_value":524072.64,"total_display":"524,072.64","shares_owned_after":11830871.0,"shares_owned_after_display":"11,830,871","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-03-12","scope":"insider"},{"id":2793002,"accession":"0001193805-24-000360","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-24-000360","line_url":"/filing/0001193805-24-000360#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"AdaptHealth Corp.","issuer_ticker":"AHCO","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Mgmt L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); DEERFIELD PARTNERS, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4495.0,"shares_display":"4,495","price_per_share":11.03,"price_display":"11.03","price_state":"stated","total_value":49579.85,"total_display":"49,579.85","shares_owned_after":11826376.0,"shares_owned_after_display":"11,826,376","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-03-12","scope":"insider"},{"id":2505760,"accession":"0001193805-24-000245","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-24-000245","line_url":"/filing/0001193805-24-000245#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1430206.0,"shares_display":"1,430,206","price_per_share":8.74,"price_display":"8.74","price_state":"stated","total_value":12500000.44,"total_display":"12,500,000.44","shares_owned_after":6151406.0,"shares_owned_after_display":"6,151,406","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-16","scope":"insider"},{"id":2505755,"accession":"0001193805-24-000245","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-24-000245","line_url":"/filing/0001193805-24-000245#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1430206.0,"shares_display":"1,430,206","price_per_share":8.74,"price_display":"8.74","price_state":"stated","total_value":12500000.44,"total_display":"12,500,000.44","shares_owned_after":6151389.0,"shares_owned_after_display":"6,151,389","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-16","scope":"insider"},{"id":2505748,"accession":"0001193805-24-000245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-24-000245","line_url":"/filing/0001193805-24-000245#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1430205.0,"shares_display":"1,430,205","price_per_share":8.74,"price_display":"8.74","price_state":"stated","total_value":12499991.7,"total_display":"12,499,991.70","shares_owned_after":4207982.0,"shares_owned_after_display":"4,207,982","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-16","scope":"insider"},{"id":6721671,"accession":"0001193805-22-001493","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-22-001493","line_url":"/filing/0001193805-22-001493#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Nuvalent, Inc.","issuer_ticker":"NUVL","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt HIF, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":650000.0,"shares_display":"650,000","price_per_share":33.5,"price_display":"33.50","price_state":"stated","total_value":21775000.0,"total_display":"21,775,000.00","shares_owned_after":650000.0,"shares_owned_after_display":"650,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-03","filed_date":"2022-11-07","scope":"insider"},{"id":6241710,"accession":"0001193805-22-001296","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-22-001296","line_url":"/filing/0001193805-22-001296#line-4","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Flynn James E; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Healthcare Innovations Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2777777.0,"shares_display":"2,777,777","price_per_share":3.15,"price_display":"3.15","price_state":"stated","total_value":8749997.55,"total_display":"8,749,997.55","shares_owned_after":4721200.0,"shares_owned_after_display":"4,721,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-20","scope":"insider"},{"id":6241707,"accession":"0001193805-22-001296","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-22-001296","line_url":"/filing/0001193805-22-001296#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Flynn James E; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Healthcare Innovations Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2777777.0,"shares_display":"2,777,777","price_per_share":3.15,"price_display":"3.15","price_state":"stated","total_value":8749997.55,"total_display":"8,749,997.55","shares_owned_after":4721197.0,"shares_owned_after_display":"4,721,197","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-20","scope":"insider"},{"id":6241704,"accession":"0001193805-22-001296","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-22-001296","line_url":"/filing/0001193805-22-001296#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Flynn James E; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Healthcare Innovations Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2777777.0,"shares_display":"2,777,777","price_per_share":3.15,"price_display":"3.15","price_state":"stated","total_value":8749997.55,"total_display":"8,749,997.55","shares_owned_after":4721183.0,"shares_owned_after_display":"4,721,183","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-20","scope":"insider"},{"id":6241701,"accession":"0001193805-22-001296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-22-001296","line_url":"/filing/0001193805-22-001296#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Flynn James E; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Healthcare Innovations Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2777777.0,"shares_display":"2,777,777","price_per_share":3.15,"price_display":"3.15","price_state":"stated","total_value":8749997.55,"total_display":"8,749,997.55","shares_owned_after":2777777.0,"shares_owned_after_display":"2,777,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-20","scope":"insider"},{"id":6241691,"accession":"0001193805-22-000932","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-22-000932","line_url":"/filing/0001193805-22-000932#line-6","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt HIF, L.P.; Flynn James E; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13132.0,"shares_display":"13,132","price_per_share":25.29,"price_display":"25.29","price_state":"stated","total_value":332108.28,"total_display":"332,108.28","shares_owned_after":1711324.0,"shares_owned_after_display":"1,711,324","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-08","scope":"insider"},{"id":6241688,"accession":"0001193805-22-000932","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193805-22-000932","line_url":"/filing/0001193805-22-000932#line-5","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt HIF, L.P.; Flynn James E; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11868.0,"shares_display":"11,868","price_per_share":25.29,"price_display":"25.29","price_state":"stated","total_value":300141.72,"total_display":"300,141.72","shares_owned_after":1546588.0,"shares_owned_after_display":"1,546,588","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-08","scope":"insider"},{"id":6241686,"accession":"0001193805-22-000932","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-22-000932","line_url":"/filing/0001193805-22-000932#line-4","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt HIF, L.P.; Flynn James E; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6909.0,"shares_display":"6,909","price_per_share":24.47,"price_display":"24.47","price_state":"stated","total_value":169063.23,"total_display":"169,063.23","shares_owned_after":1704244.0,"shares_owned_after_display":"1,704,244","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-08","scope":"insider"},{"id":6241684,"accession":"0001193805-22-000932","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-22-000932","line_url":"/filing/0001193805-22-000932#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt HIF, L.P.; Flynn James E; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6243.0,"shares_display":"6,243","price_per_share":24.47,"price_display":"24.47","price_state":"stated","total_value":152766.21,"total_display":"152,766.21","shares_owned_after":1540190.0,"shares_owned_after_display":"1,540,190","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-08","scope":"insider"},{"id":6241681,"accession":"0001193805-22-000932","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-22-000932","line_url":"/filing/0001193805-22-000932#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt HIF, L.P.; Flynn James E; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":171.0,"shares_display":"171","price_per_share":25.08,"price_display":"25.08","price_state":"stated","total_value":4288.68,"total_display":"4,288.68","shares_owned_after":1711153.0,"shares_owned_after_display":"1,711,153","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-08","scope":"insider"},{"id":6241676,"accession":"0001193805-22-000932","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-22-000932","line_url":"/filing/0001193805-22-000932#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt HIF, L.P.; Flynn James E; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155.0,"shares_display":"155","price_per_share":25.08,"price_display":"25.08","price_state":"stated","total_value":3887.4,"total_display":"3,887.40","shares_owned_after":1546433.0,"shares_owned_after_display":"1,546,433","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-08","scope":"insider"},{"id":5512428,"accession":"0001193805-21-001014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-001014","line_url":"/filing/0001193805-21-001014#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Private Design Fund IV, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99325.0,"shares_display":"99,325","price_per_share":15.81,"price_display":"15.81","price_state":"stated","total_value":1570328.25,"total_display":"1,570,328.25","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-09","filed_date":"2021-07-13","scope":"insider"},{"id":5471352,"accession":"0001193805-21-000999","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-21-000999","line_url":"/filing/0001193805-21-000999#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6837.0,"shares_display":"6,837","price_per_share":15.869,"price_display":"15.87","price_state":"stated","total_value":108496.353,"total_display":"108,496.35","shares_owned_after":99325.0,"shares_owned_after_display":"99,325","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-07","filed_date":"2021-07-07","scope":"insider"},{"id":5471349,"accession":"0001193805-21-000999","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-21-000999","line_url":"/filing/0001193805-21-000999#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49239.0,"shares_display":"49,239","price_per_share":16.195,"price_display":"16.20","price_state":"stated","total_value":797425.605,"total_display":"797,425.60","shares_owned_after":106162.0,"shares_owned_after_display":"106,162","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-06","filed_date":"2021-07-07","scope":"insider"},{"id":5471346,"accession":"0001193805-21-000999","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-000999","line_url":"/filing/0001193805-21-000999#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10599.0,"shares_display":"10,599","price_per_share":17.011,"price_display":"17.01","price_state":"stated","total_value":180299.589,"total_display":"180,299.59","shares_owned_after":155401.0,"shares_owned_after_display":"155,401","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-07","scope":"insider"},{"id":5242047,"accession":"0001193805-21-000974","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-21-000974","line_url":"/filing/0001193805-21-000974#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Flynn James E; Deerfield Mgmt HIF, L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":228571.0,"shares_display":"228,571","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":1999996.25,"total_display":"1,999,996.25","shares_owned_after":1943423.0,"shares_owned_after_display":"1,943,423","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-30","filed_date":"2021-07-02","scope":"insider"},{"id":5242044,"accession":"0001193805-21-000974","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-21-000974","line_url":"/filing/0001193805-21-000974#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Flynn James E; Deerfield Mgmt HIF, L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":228570.0,"shares_display":"228,570","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":1999987.5,"total_display":"1,999,987.50","shares_owned_after":1943420.0,"shares_owned_after_display":"1,943,420","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-30","filed_date":"2021-07-02","scope":"insider"},{"id":5242040,"accession":"0001193805-21-000974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-000974","line_url":"/filing/0001193805-21-000974#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Flynn James E; Deerfield Mgmt HIF, L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":228569.0,"shares_display":"228,569","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":1999978.75,"total_display":"1,999,978.75","shares_owned_after":1943406.0,"shares_owned_after_display":"1,943,406","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-30","filed_date":"2021-07-02","scope":"insider"},{"id":4922937,"accession":"0001193805-21-000800","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193805-21-000800","line_url":"/filing/0001193805-21-000800#line-5","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Singular Genomics Systems, Inc.","issuer_ticker":"OMIC","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Mgmt L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); DEERFIELD PARTNERS, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1050000.0,"shares_display":"1,050,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":23100000.0,"total_display":"23,100,000.00","shares_owned_after":1627148.0,"shares_owned_after_display":"1,627,148","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-03","scope":"insider"},{"id":4922933,"accession":"0001193805-21-000800","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-21-000800","line_url":"/filing/0001193805-21-000800#line-4","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Singular Genomics Systems, Inc.","issuer_ticker":"OMIC","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Mgmt L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); DEERFIELD PARTNERS, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":9900000.0,"total_display":"9,900,000.00","shares_owned_after":7484871.0,"shares_owned_after_display":"7,484,871","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-03","scope":"insider"},{"id":5284358,"accession":"0001193805-21-000435","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-21-000435","line_url":"/filing/0001193805-21-000435#line-4","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Mgmt IV, L.P.; Deerfield Private Design Fund IV, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","shares_owned_after":3933137.0,"shares_owned_after_display":"3,933,137","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2021-03-30","scope":"insider"}],"next_cursor":"2021-03-30|5284358","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001374690","name":"Larimar Therapeutics, Inc.","url":"/issuer/0001374690","role":"Director, Ten percent owner, Other","n_filings":5,"first_seen":"2021-07-02","last_seen":"2026-03-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001861560","name":"Nuvalent, Inc.","url":"/issuer/0001861560","role":"Director, Ten percent owner, Other","n_filings":3,"first_seen":"2022-11-07","last_seen":"2025-11-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001671858","name":"ARS Pharmaceuticals, Inc.","url":"/issuer/0001671858","role":"Ten percent owner","n_filings":2,"first_seen":"2024-11-13","last_seen":"2025-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001725255","name":"AdaptHealth Corp.","url":"/issuer/0001725255","role":"Director, Ten percent owner, Other","n_filings":2,"first_seen":"2018-02-23","last_seen":"2024-03-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001759425","name":"Mirum Pharmaceuticals, Inc.","url":"/issuer/0001759425","role":"Ten percent owner, Other","n_filings":4,"first_seen":"2019-07-24","last_seen":"2022-06-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001850906","name":"Singular Genomics Systems, Inc.","url":"/issuer/0001850906","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2021-06-03","last_seen":"2021-06-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001710072","name":"Edgewise Therapeutics, Inc.","url":"/issuer/0001710072","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2021-03-30","last_seen":"2021-03-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001528115","name":"Annexon, Inc.","url":"/issuer/0001528115","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2020-07-28","last_seen":"2020-07-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001787400","name":"Nkarta, Inc.","url":"/issuer/0001787400","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2020-07-14","last_seen":"2020-07-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001628171","name":"Revolution Medicines, Inc.","url":"/issuer/0001628171","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2020-02-18","last_seen":"2020-02-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001490978","name":"Schrodinger, Inc.","url":"/issuer/0001490978","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2020-02-10","last_seen":"2020-02-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001759138","name":"Cabaletta Bio, Inc.","url":"/issuer/0001759138","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2019-10-30","last_seen":"2019-10-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001703647","name":"Frequency Therapeutics, Inc.","url":"/issuer/0001703647","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2019-10-07","last_seen":"2019-10-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001655759","name":"ARVINAS INC.","url":"/issuer/0001655759","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2018-10-01","last_seen":"2018-10-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001680307","retrieved_at":"2026-08-21T20:04:04+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}